Boothbay Fund Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.37M | Buy |
10,922
+9,112
| +503% | +$1.14M | 0.03% | 446 |
|
2025
Q1 | $248K | Buy |
+1,810
| New | +$248K | 0.01% | 947 |
|
2023
Q1 | – | Sell |
-850
| Closed | -$235K | – | 1880 |
|
2022
Q4 | $235K | Sell |
850
-1,077
| -56% | -$298K | 0.01% | 1301 |
|
2022
Q3 | $515K | Sell |
1,927
-18,225
| -90% | -$4.87M | 0.01% | 1053 |
|
2022
Q2 | $4.11M | Buy |
20,152
+2
| +0% | +$408 | 0.11% | 219 |
|
2022
Q1 | $4.24M | Sell |
20,150
-3,217
| -14% | -$678K | 0.1% | 209 |
|
2021
Q4 | $5.61M | Buy |
23,367
+13,079
| +127% | +$3.14M | 0.13% | 133 |
|
2021
Q3 | $2.91M | Sell |
10,288
-9,233
| -47% | -$2.61M | 0.08% | 241 |
|
2021
Q2 | $6.76M | Buy |
19,521
+17,741
| +997% | +$6.14M | 0.22% | 76 |
|
2021
Q1 | $498K | Sell |
1,780
-700
| -28% | -$196K | 0.02% | 769 |
|
2020
Q4 | $607K | Buy |
2,480
+1,333
| +116% | +$326K | 0.02% | 556 |
|
2020
Q3 | $325K | Sell |
1,147
-4,166
| -78% | -$1.18M | 0.02% | 673 |
|
2020
Q2 | $1.42M | Sell |
5,313
-906
| -15% | -$242K | 0.1% | 232 |
|
2020
Q1 | $1.97M | Sell |
6,219
-781
| -11% | -$247K | 0.16% | 133 |
|
2019
Q4 | $2.08M | Sell |
7,000
-1,085
| -13% | -$322K | 0.18% | 129 |
|
2019
Q3 | $1.88M | Buy |
8,085
+877
| +12% | +$204K | 0.17% | 131 |
|
2019
Q2 | $1.69M | Sell |
7,208
-7,679
| -52% | -$1.8M | 0.15% | 129 |
|
2019
Q1 | $3.52M | Buy |
+14,887
| New | +$3.52M | 0.34% | 43 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 593 |
|
2017
Q1 | – | Sell |
-1,847
| Closed | -$524 | – | 657 |
|
2016
Q4 | $524 | Buy |
1,847
+241
| +15% | +$68 | 0.12% | 176 |
|
2016
Q3 | $503K | Sell |
1,606
-25,632
| -94% | -$8.03M | 0.11% | 166 |
|
2016
Q2 | $912K | Buy |
+27,238
| New | +$912K | 0.35% | 55 |
|